A healthcare hedge fund just locked in gains on one of its biggest winners—here’s what that move really signals.

Travere Therapeutics (TVTX) continues to operate at a loss, with net losses expanding at an average annual rate of 11.7% over the past five years. However, the outlook for earnings is robust, with ...

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life ...

Travere Therapeutics reported third-quarter 2025 earnings, highlighting revenue of US$164.86 million and net income of US$25.71 million, a sharp turnaround from the net loss a year earlier, with ...

The U.S. Food and Drug Administration has approved Otsuka's injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday. The ...

Travere Therapeutics Inc. reported a strong financial performance for the third quarter of 2025, with earnings per share (EPS) of $0.59, significantly surpassing the forecasted loss of $0.29. The ...

On Tuesday, 11 November 2025, Travere Therapeutics (NASDAQ:TVTX) presented at the Guggenheim Securities 2nd Annual Healthcare Innovation Conference. The company highlighted strategic advancements in ...

Travere Therapeutics (TVTX) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of a loss of $0.31 per share. This compares to a loss of $0.7 per share a year ago ...

We recently published 10 Stocks With Easy 20-40% Gains. Travere Therapeutics, Inc. (NASDAQ:TVTX) is one of the last week's best-performing stocks. Travere Therapeutics soared by 25.3 percent ...

Travere Therapeutics (TVTX) reported $164.86 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 162.1%. EPS of $0.28 for the same period compares to -$0 ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Travere Therapeutics, Inc. (TVTX) on Thursday reported third-quarter earnings of $25.7 million. On a per-share basis, the San Diego-based company said it had net ...